LONDON — Growth at Unilever’s beauty and well-being division outstripped the consumer giant’s overall performance in 2025, with brands including Nutrafol, Liquid I.V., Vaseline and Dove leading the way. Underlying sales in the division grew 4.3 percent to 12.8 billion euros, driven by a balance of volume and price growth. Wellness products as well as Vaseline and Dove grew in the double digits. By contrast, growth in prestige beauty, core skin care and hair care, was in the low-to-midsingle digits. More f ...

Financial Data and Key Metrics Changes - Unilever reported a 4% underlying sales growth in Q3 2025, with a volume growth acceleration to 1.7% excluding ice cream, despite subdued markets [2][4] - The underlying sales growth was 3.9% with underlying price growth at 2.4% and volume contributing 1.5% [7][8] - Turnover for Q3 was EUR 14.7 billion, down 3.5% year on year, with a negative currency impact of 6.1% [27][28] Business Line Data and Key Metrics Changes - Beauty and Well-being saw a 5.1% underlying sales growth, driven by strong volume growth [15] - Personal Care achieved a 4.1% underlying sales growth, with volume growth of 1% and price growth of 3.1% [17] - Home Care underlying sales grew 3.1%, with volume growth of 2.5% and price growth of 0.6% [20] Market Data and Key Metrics Changes - North America grew underlying sales by 5.5%, with volume growth of 5.4%, driven by Personal Care and Well-being brands [9][10] - Europe experienced a 1.1% underlying sales growth, with a 0.6% decline in volume and 1.7% growth from price [10][11] - Emerging markets grew by 4.1%, led by a return to growth in Indonesia and China [4][12] Company Strategy and Development Direction - The company is focusing on premium segments and fast-growing channels, with a significant shift towards digital commerce [2][32] - Unilever is preparing for the demerger of its ice cream business, expected to be completed in 2025 [5][26] - The strategic priority is to strengthen the portfolio with more beauty, well-being, and personal care products [32][34] Management's Comments on Operating Environment and Future Outlook - Management remains confident in achieving full-year outlook despite some softness in certain markets, particularly Latin America [30][31] - The company expects underlying sales growth to remain within the 3% to 5% multiyear range, with volume growth in Q4 expected to be at least in line with Q3 [30][31] - Management highlighted the importance of premium innovations and brand investments to drive future growth [34][36] Other Important Information - The company is experiencing a significant shift in consumer behavior towards premium products and digital channels [32][34] - The macroeconomic environment in India is favorable, with recent tax reforms expected to boost consumption [12][14] - The company is committed to maintaining competitive pricing while managing inflationary pressures [57][58] Q&A Session Summary Question: Clarification on volume growth expectations into 2026 - Management confirmed a 2% volume growth expectation into 2026, reflecting confidence in long-term market performance [37][50] Question: Growth of well-being and prestige brands in North America - Management reported strong double-digit growth in well-being brands like Liquid IV and Nutrafol, with a recovery in prestige beauty brands [41][42] Question: Actions taken in Latin America due to macroeconomic pressures - Management acknowledged challenges in Brazil and highlighted corrective actions taken in pricing and product formats to regain competitiveness [45][49] Question: Pricing outlook in a benign commodity cost environment - Management indicated that while commodity costs are benign, pricing adjustments will be necessary to manage inflationary pressures [53][58] Question: Performance of hair care brands in the U.S. - Management noted that TRESemmé has returned to growth in Q3, while some brands were consciously delisted to focus on sustainable growth [64][66] Question: Update on Liquid IV's global rollout - Management confirmed that Liquid IV is performing well in the U.S. and has been rolled out to eight markets, with plans for further expansion [66][67] Question: Performance in Mexico and expectations for hard currency earnings - Management reported soft market conditions in Mexico but expressed confidence in achieving positive hard currency earnings for the year [92][96] Question: Performance in Indonesia and China - Management expressed satisfaction with the growth in Indonesia and noted improvements in China, with all business groups returning to growth [99][101]

Core Insights - Unilever's beauty and well-being sales drove a 3.9% underlying group sales growth to 14.7 billion euros in Q3 [1][2] - The beauty and well-being division reported a 5.1% underlying sales growth to 3.2 billion euros, marking the highest growth within the group [2][3] - Overall sales at actual exchange fell 3.5% year-on-year due to net disposals and currency headwinds [2] Beauty and Well-Being Division Performance - Top performers included Dove hair, Vaseline, Liquid I.V., Nutrafol, Hourglass, and K18, all achieving double-digit growth [3] - Prestige beauty grew at mid-single digits, while Paula's Choice and Dermalogica returned to low-single-digit growth after previous declines [3] - Liquid I.V.'s sugar-free range, launched in mid-2023, now accounts for nearly 30% of total brand sales [4] Personal Care Division Performance - The personal care division saw a 4.1% underlying sales growth to 3.3 billion euros, with strong performance from Dove's premium innovations [4] Future Outlook - The CEO stated that the full-year underlying sales growth is expected to be between 3% and 5%, with second-half growth anticipated to exceed the first half [5] - An improvement in underlying operating margin is expected for the full year, with second-half margins projected to be at least 18.5% [6] Market Dynamics - Emerging markets like Indonesia and China returned to growth, driven by Unilever's power brands [7] - Significant investments in manufacturing, logistics, and e-commerce in China contributed to the growth across all major divisions [8] Strategic Focus - Unilever is prioritizing beauty, well-being, and personal care, with a focus on premium segments and digital commerce [9] - The underlying growth exceeded analysts' expectations of 3.7% [9] Market Reaction - RBC Capital Markets described the third-quarter numbers as "reassuring," with encouraging momentum in China and India expected to accelerate in Q4 [10]

Core Viewpoint - Unilever's financial performance in the first half of 2025 shows a decline in overall revenue but indicates a positive trend in strategic transformation and market focus, particularly in the Chinese market [2][4][30]. Financial Performance - Total revenue for the first half of 2025 was €3.01 billion (approximately ¥24.76 billion), a year-on-year decrease of 3.2%, primarily due to currency fluctuations (-4.0%) and business adjustments (-2.5%), while underlying sales grew by 3.4% [2]. - Operating profit was €530 million (approximately ¥4.37 billion), reflecting a significant year-on-year drop of 10.6% [2]. Strategic Focus - CEO Fernando Fernandez emphasized the importance of "focus" and "agility" in driving growth, highlighting the company's strategic correctness in both developed and emerging markets [4]. - Unilever is undergoing a profound transformation, with plans to spin off its ice cream business and leverage influencer marketing as a new growth engine [4][12]. China Market Insights - In China, Unilever's underlying sales saw a slight decline in the first half, but improvements were noted in the second quarter, suggesting that recent adjustments are beginning to yield results [6][26]. - The company is accelerating premiumization and localized innovation, exemplified by the launch of the Vaseline Water Radiance Body Essence series tailored for Chinese consumers [8][27]. Regional Performance - Revenue contributions from developed markets (44%) and emerging markets (56%) showed growth rates of 4.3% and 2.8%, respectively, indicating that the Chinese market is crucial for the group's return to positive growth [10][30]. - The beauty and personal care segments generated €650 million (approximately ¥5.35 billion) in revenue, with underlying sales growth of 3.7% and 4.8% [10]. Business Restructuring - Unilever is actively engaged in mergers and acquisitions, focusing on high-end beauty and personal care brands, while divesting non-core assets to optimize its business portfolio [13][16]. - The company has made several acquisitions, including a 90.5% stake in the high-end beauty brand Minimalist and the purchase of the UK-based eco-friendly personal care brand Wild [16][17]. Marketing Strategy - Unilever is shifting towards a "influencer-first" strategy, planning to increase social media spending from 30% to 50% of its total advertising budget and expand collaborations with influencers [18][19]. - This strategy aims to enhance brand relevance and connection with younger consumers, particularly in the beauty sector [20]. Future Directions - Unilever's three core development directions include enhancing beauty and health, increasing investments in the U.S. and Indian markets, and deepening high-end and digital transformation [22][23][24]. - The company anticipates a rebound in the Chinese market, supported by regional growth and strategic adjustments, with expectations of a sales growth rate between 3% and 5% for the full year [30][29].

Financial Data and Key Metrics Changes - Underlying sales growth for the first half was 3.4%, with volumes contributing 1.5% and price growth at 1.9% [8][31] - Turnover for the first half was €30.1 billion, down 3.2% year on year, primarily due to a negative currency impact of 4% [31][36] - Underlying operating profit was €5.8 billion, a decline of 4.8% versus the prior year, with underlying earnings per share at €1.59, down 2.1% [36] Business Line Data and Key Metrics Changes - Beauty and Well-being underlying sales growth was 3.7%, driven by 1.7% volume and 2% price [15] - Personal Care delivered 4.8% underlying sales growth, with 1.4% from volume and 3.3% from price [19] - Homecare underlying sales grew 1.3%, with 1.1% from volume and 0.2% from price [23] - Foods delivered competitive sales growth of 2.2%, with 0.3% from volume and 1.9% from price [25] - Ice cream underlying sales grew 5.9%, driven by a 3.8% increase in volume and 2% price growth [26] Market Data and Key Metrics Changes - Developed markets represented 44% of group turnover, with first half underlying sales growth of 4.3% [10] - North America saw underlying sales growth of 5.4%, with volumes up 3.7% [5] - Asia Pacific Africa, representing 43% of group turnover, delivered underlying sales growth of 3.5% [12] - Latin America grew only 0.5%, with a 4.6% decline in volume [13] Company Strategy and Development Direction - The company is focused on a transformation towards beauty and well-being, with significant investments in premium brands and innovation [50][56] - The demerger of the ice cream business is set for mid-November, with plans to retain a stake of just below 20% [28][29] - The company aims for multiyear volume growth of at least 2% and consistent gross margin expansion [47][56] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving a second half underlying sales growth of 3% to 5%, with expectations for improved performance in emerging markets [42][46] - The macroeconomic environment remains uncertain, particularly in Latin America and China, but there are signs of recovery in India and Indonesia [46][94] - The company anticipates an improvement in underlying operating margin for the full year, with second half margins expected to be at least 18.5% [42][60] Other Important Information - The company completed a share buyback program of €1.5 billion, contributing 1.5% to earnings in the first half [38][41] - Free cash flow for 2025 was €1.1 billion, down from €2.2 billion in the prior year due to lower operating profit and ice cream separation costs [38][39] Q&A Session Summary Question: Expectations for ex-ice cream performance and volume acceleration - Management expects volume growth of about 2% for the remaining company in the second half, supported by improved market conditions and strong brand investments [63][65] Question: Insights on M&A strategy and recent acquisitions - The company remains committed to bolt-on M&A, focusing on beauty and personal care brands with strong digital presence and functionality, such as Doctor Squatch and Wilde [71][72] Question: Outlook for Latin America and performance in key markets - Management acknowledged a weak quarter in Latin America, with challenges in Brazil and Mexico, but expects improvements in the second half as pricing strategies are adjusted [77][81] Question: Recovery expectations in Asia, particularly India and Indonesia - Management is optimistic about growth in India, with strong performance in Home Care and e-commerce, while Indonesia is expected to show positive volume growth in the second half [89][92]

Financial Data and Key Metrics Changes - Underlying sales growth for the first half of 2025 was 3.4%, with volumes contributing 1.5% and price growth at 1.9% [6][30] - Turnover for the first half was €30.1 billion, down 3.2% year on year, primarily due to a negative currency impact of 4% [30][36] - Underlying operating profit was €5.8 billion, a decline of 4.8% versus the prior year, and underlying earnings per share was €1.59, down 2.1% [34][36] Business Line Data and Key Metrics Changes - Beauty and Well-being achieved underlying sales growth of 3.7%, driven by 1.7% volume and 2% price [14] - Personal Care delivered 4.8% underlying sales growth, with 1.4% from volume and 3.3% from price [17] - Homecare underlying sales grew 1.3%, with 1.1% from volume and 0.2% from price [21] - Foods delivered competitive sales growth of 2.2%, with 0.3% from volume and 1.9% from price [23] - Ice cream underlying sales grew 5.9%, driven by a 3.8% increase in volume and 2% price growth [24] Market Data and Key Metrics Changes - Developed markets represented 44% of group turnover, with first half underlying sales growth of 4.3% [8] - North America saw underlying sales growth of 5.4%, with volumes up 3.7% [4] - Asia Pacific Africa, representing 43% of group turnover, delivered underlying sales growth of 3.5% [11] - Latin America grew only 0.5%, with a 4.6% decline in volume due to challenging macroeconomic conditions [12] Company Strategy and Development Direction - The company is focused on a transformation towards beauty and well-being, with significant investments in premium brands and innovation [48][54] - The demerger of the ice cream business is set for mid-November, with the intention to retain a stake of just below 20% in the new entity [26][27] - The company aims for multiyear volume growth of at least 2% and consistent gross margin expansion, targeting mid-single digit underlying sales growth [45][54] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving a second half underlying sales growth of 3% to 5%, supported by strong performance in developed markets and improving trends in emerging markets [41][44] - The company anticipates an improvement in underlying operating margin for the full year, with second half margins expected to be at least 18.5% [41][54] - Management acknowledged challenges in Latin America and China but expects improvements in the second half due to operational interventions [44][92] Other Important Information - The company completed a share buyback program of €1.5 billion, contributing 1.5% to earnings in the first half [36][39] - Free cash flow for 2025 was €1.1 billion, down from €2.2 billion in the prior year due to lower operating profit and ice cream separation costs [36][37] Q&A Session Summary Question: Expectations for ex-ice cream performance and volume acceleration - Management expects to achieve volume growth of about 2% for the remaining company in the second half, supported by improved market conditions and strong brand investments [61][63] Question: Insights on M&A strategy and recent acquisitions - The company remains committed to bolt-on M&A, focusing on acquiring brands with strong digital presence and functionality, such as Doctor Squatch and Wilde [70][72] Question: Outlook for Latin America and performance in key markets - Management noted a weak quarter in Latin America due to economic pressures but expects improvements with strategic pricing adjustments and innovation [76][80] Question: Recovery expectations in Asia, particularly India and Indonesia - Management is optimistic about growth in India, expecting continued volume increases, while Indonesia is showing signs of recovery with improved fundamentals [88][90]